Aubrey de Grey, Ph.D, to present on “Rejuvenation biotechnology: why age may soon cease to mean aging” and Salaheldin Halasa, MD, to present on “Modulating the immune system to manage chronic diseases.”
MIAMI, February 22, 2021 – The American Academy of Stem Cell Physicians will be hosting two sought-after virtual lectures tomorrow, Wednesday, March 3rd, 2021.
The first, 7:30pm (Eastern) lecture will feature Dr. Aubrey de Grey, Ph.D., who will present on “Rejuvenation biotechnology: why age may soon cease to mean aging”. Dr. Aubrey de Grey is a biomedical gerontologist based in Mountain View, California, USA, and is the Chief Science Officer (CSO) of SENS Research Foundation, a California-based 501(c)(3) biomedical research charity that performs and funds laboratory research dedicated to combating aging. He is also the Editor-in-Chief of Rejuvenation Research, the world’s highest-impact peer-reviewed journal focused on intervention in aging. He received his BA in computer science and Ph.D. in biology from the University of Cambridge.
His research interests encompass the characterization of all the types of self-inflicted cellular and molecular damage that constitute mammalian aging and the design of interventions to repair and/or obviate that damage. Dr. de Grey is a Fellow of both the Gerontological Society of America and the American Aging Association, and sits on the editorial and scientific advisory boards of numerous journals and organizations. He is a highly sought-after speaker who gives 40-50 invited talks per year at scientific conferences, universities, companies in areas ranging from pharma to life insurance, and to the public.
The second, 8:30pm (Eastern) features Saladeldin Halasa, MD, “Modulating the immune system to manage chronic diseases.” Dr. Halasa is the Founder of Chronic Disease Prevention and Management Centers established in 2020 by a team of medical professionals with years of experience in protocols related to photodynamic therapy, photoregenerative therapy, Nitroredox therapy and Nanomedicine. These inventions are intended to provide medical treatments for oxidative stress related diseases such as degenerative diseases, immunological diseases, chronic infectious diseases, cancers and a broad range of unmet medical needs involving chronic inflammation with an emphasis on pain management.
Dr. A.J. Farshchian, a spokesperson and founder for the The American Academy of Stem Cell Physicians, earlier today said, “The American Academy of Stem Cell Physicians always puts education at the forefront. We believe that hosting Aubrey de Grey, Ph.D., and Salaheldin Halasa, MD will do just that. The field of regenerative medicine is growing at an extremely rapid pace. Therefore, the American Academy of Stem Cell Physicians believes the best way to stay ahead and informed is by learning through celebrated lecturers. The clinical pearls taken from these lectures are invaluable so we urge all members and non-members to come and participate to the best of their abilities.”
Darcy DiFede, RN, BSN, FAHA, director of research, stated “Dr. Aubrey de Grey’s work holds great promise in potentially halting the hands of time. My experience with aging frailty and mesenchymal stem cell research was just the tip of the iceberg. Congratulations Aubrey for your extraordinary journey toward finding the key to longevity.”
The goal of The American Academy of Stem Cell Physicians, is to create an innovative platform within an open forum for sharing knowledge and experiences. It expert speakers range in degree of specialties to ensure that captivating new topics are covered every Wednesday.
To join this zoom lecture, please text (305) 439-8766. Please text as soon as possible due to limited availability.
The American Academy of Stem Cell Physicians (AASCP) is a non-profit organization created to advance knowledge in research and the development of therapeutics in regenerative medicine. To learn more, visit AASCP.net